how cryptocurrency works Featured snippets

Rifa Seiki: Xunmi Technology went to the company to investigate and discuss products such as end-horizontal machining center and thread grinder. On December 11th, Xunmi Technology co-president Lei Ming and his party visited and investigated Seiki Seiki in Japan. Chasing technology has visited the production workshop of Maichuang and bearing equipment in depth, and gained an in-depth understanding of the specific situation of products such as high-end horizontal machining center and thread grinder of Nissan Seiki from research and development to production. Not only that, the two sides also conducted in-depth exchanges and discussions on the intelligent production line structure, core components, product accuracy and related issues in the practical application of a complete set of solutions. According to the data, Chasing Technology began to lay out robots in 2021, and successively launched bionic quadruped robot dogs, universal humanoid robots and other products. In September this year, Xunmi Technology released X50 series sweeping robots, equipped with the world's first "bionic mechanical foot obstacle-crossing technology".The ethylene plant of ExxonMobil Huizhou Ethylene Phase I Project entered the commissioning stage, and ExxonMobil China announced that in December 2024, the 1.6 million tons ethylene plant of ExxonMobil Huizhou Ethylene Phase I Project was handed over to China and entered the commissioning stage in an all-round way. ExxonMobil Huizhou Ethylene Project is located in Huizhou Daya Bay Petrochemical Park. The first phase of the project mainly includes ethylene plants, high-end polyethylene and polypropylene production plants in the middle and lower reaches, and supporting utilities, docks, storage and transportation and environmental protection facilities.Shibor reported 1.4820% overnight, down 4.6 basis points; In 7 days, shibor reported 1.6350%, down 8.7 basis points; In three months, shibor reported 1.7400%, down 0.4 basis points.

The Nikkei 225 index closed at 39,881.10 points in early trading, up 1.29%.The next "explosion point" of biomedicine may appear in Shenzhen. "China's pharmaceutical innovation ranks first in the second echelon in the world in terms of the quantitative indicators of R&D pipelines and listed new drugs." A few days ago, Song Ruilin, executive president of China Pharmaceutical Innovation Promotion Association, held the "Star of the Bay Area" biomedical source innovation conference in Shenzhen, and believed that China's pharmaceutical research and industrial development were entering a new stage of innovation. Chen Qiyu, vice president of China Pharmaceutical Innovation Promotion Association and executive director and co-CEO of Fosun International, said that Shenzhen has great advantages and development momentum in linking Greater Bay Area's urban development and AI technology. By leveraging the resources in the Bay Area and making good use of these advantages, it is possible to find a new fulcrum in the future biomedical R&D innovation track, and the next "explosion point" of biomedicine is likely to appear in Shenzhen.The Hang Seng Index rose more than 1%, the Hang Seng Technology Index rose 1.47%, and the technology stocks strengthened.

Yunnan Germanium Industry: downstream customers didn't feedback that the company germanium was directly used in quantum chip products. Some investors asked Yunnan Germanium Industry (002428) on the interactive platform: in quantum computing and quantum communication, germanium is widely used in the manufacturing process of quantum chips, which can achieve excellent performance. Excuse me, does the company have germanium products used in quantum chips? Yunnan Germanium Industry replied that at present, the downstream customers of the company have not reported to the company that it is directly used in this product.The individual pension system has been extended to the whole country. (Xinhua News Agency)Xiong 'an Center of Beijing-Tianjin-Hebei National Technology Innovation Center officially started operation. On December 12th, Xiong 'an Center of Beijing-Tianjin-Hebei National Technology Innovation Center officially started operation, including the cooperation project of Xiong 'an Medical and Industrial Cross Transformation Research Institute of Peking University People's Hospital and the fourth generation semiconductor material doped AlN epitaxial wafer, and many independent innovative projects landed in xiong'an new area. As a national innovation platform, Xiong 'an Center will focus on key tasks such as building a first-class innovation platform, forming a composite innovation team, and improving the innovation and entrepreneurship ecology, and strive to create an important source of independent innovation and original innovation. (CCTV News)